查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946614

基于NGS的RNA定序全球市场报告（2026年）

NGS-Based RNA-Sequencing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基于次世代定序（NGS）的RNA定序市场发展迅速，预计将从2025年的42亿美元成长到2026年的52.7亿美元，复合年增长率（CAGR）为25.3%。过去几年的增长可归因于基因组研究倡议的扩展、定序技术成本的下降、RNA测序在学术研究中的日益普及、先进定序平台的广泛应用以及生物信息学能力的提升。

基于次世代定序(NGS) 的 RNA定序市场预计将在未来几年呈指数级增长，到 2030 年将达到 127.3 亿美元，复合年增长率 (CAGR) 为 24.7%。预测期内的成长要素包括：RNA 定序在临床诊断中的应用日益广泛、精准医疗投资不断增加、药物研发应用不断扩展、对整合资料分析解决方案的需求不断增长，以及对多体学研究的日益重视。预测期内的关键趋势包括：高通量 RNA定序平台的日益普及、对单细胞 RNA定序的需求不断增长、基于云端的生物资讯分析应用日益广泛、转录组学在精准医疗中的应用不断扩展，以及对数据准确性和扩充性的日益关注。

预计不断扩张的製药业将推动基于次世代定序（NGS）的RNA定序市场持续成长。製药业涵盖公共和私营机构所进行的药品研发和生产活动。在该领域，基于NGS的RNA定序被广泛用于进行全面的基因表现分析、识别和检验潜在的药物标靶、评估药物反应以及深入了解疾病生物学，从而支持更高效、数据驱动的药物发现和开发。例如，根据欧洲製药工业协会联合会（EFPIA）的数据，截至2024年11月，预计北美将占2024年全球药品销售额的54.8%，而欧洲占22.7%。因此，製药业的扩张显着促进了基于NGS的RNA定序市场的成长。

基于新一代定序（NGS）技术的RNA定序市场中的主要企业正致力于开发创新产品，例如先进的小RNA定序试剂盒，以简化工作流程并提高RNA表现研究的准确性和效率。这些先进的小RNA定序试剂盒是新一代样品製备方案，旨在精确捕获和定序小RNA分子，从而帮助研究人员缩短处理时间，减少接头二聚体等技术误差，并产生更一致、更可重复的表达数据。例如，2025年10月，总部位于奥地利的生技公司Lexogen发布了miRVEL Profiling Small RNA-Seq Library Prep Kit，旨在简化和优化小RNA研究工作流程。该试剂盒可在7小时内製备定序就绪的文库，操作时间极短，并透过先进的接头封闭技术最大限度地减少接头二聚体的形成。此外，该试剂盒在各种起始量下均表现出高度可重复的性能，并整合了一个8核苷酸特异性双索引，用于精确的多重定序和读段分配。 miRVEL 分析试剂盒支援多种应用，包括RNA干扰研究、宿主防御机制研究以及植物和农业中的小 RNA 分析。它还相容于 Lexogen 的 SPLIT RNA 萃取试剂盒和 TraPR 小 RNA 富集系统，为小 RNA定序提供全面的端到端解决方案。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球基于NGS的RNA定序市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 高通量RNA定序平台的应用日益广泛
    • 单细胞RNA定序需求不断成长
    • 扩大基于云端的生物资讯分析的应用
    • 拓展转录组学在精准医学的应用
    • 更加重视数据准确性和扩充性

第五章 终端用户产业市场分析

  • 研究和学术机构
  • 医院和诊所
  • 製药公司
  • 生技公司
  • 基因组学服务供应商

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球基于NGS的RNA定序市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球基于NGS的RNA定序市场规模、比较及成长率分析
  • 全球基于NGS的RNA定序市场表现：规模与成长，2020-2025年
  • 全球基于NGS的RNA定序市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按产品和服务分类
  • 样品製备产品、定序平台和耗材、定序服务、数据分析、储存和管理
  • 透过技术
  • 合成定定序、离子半导体定序、单分子即时定序、奈米孔定序
  • 透过使用
  • 表达谱分析、小RNA定序和从头转录组组装
  • 最终用户
  • 研究和学术机构、製药和生物技术公司以及其他最终用户
  • 依类型细分：样品製备产品
  • RNA萃取试剂盒、文库建构试剂盒、逆转录试剂盒、品管试剂
  • 按类型细分：定序平台和耗材
  • 定序设备、定序耗材
  • 按类型细分：定序服务
  • 合定序服务、客製化样品製备服务、咨询和实验设计服务
  • 按类型细分：资料分析、储存和管理
  • 生物资讯软体、数据分析服务、基于云端的数据储存解决方案和数据管理平台

第十章 区域与国家分析

  • 全球基于NGS的RNA定序市场：按地区划分，实际结果和预测，2020-2025年，2025-2030年预测，2035年预测
  • 全球基于NGS的RNA定序市场：依国家划分，实际结果与预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 基于NGS的RNA定序市场：竞争格局与市场份额，2024年
  • 基于NGS的RNA定序市场：公司估值矩阵
  • 基于新一代定序技术的RNA定序市场：公司概况
    • Illumina Inc.
    • Thermo Fisher Scientific Inc.
    • Oxford Nanopore Technologies Ltd.
    • Agilent Technologies Inc.
    • BGI Group

第37章：其他领先和创新企业

  • QIAGEN NV, Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear BV, Otogenetics Corporation

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 基于NGS的RNA定序市场展望（2030年）：提供新机会的国家
  • 基于NGS的RNA定序市场展望（2030年）：新兴细分市场机会
  • 基于新一代定序技术的RNA定序市场展望（2030年）：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MNBRS01_G26Q1

NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.

The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.

Tariffs are impacting the NGS-based RNA-sequencing market by increasing costs of imported sequencing instruments, reagents, consumables, and data storage infrastructure. Research laboratories and biotechnology companies in North America and Europe are most affected due to dependence on imported platforms, while Asia-Pacific faces cost pressure on sequencing services. These tariffs are increasing operational costs and slowing technology upgrades. However, they are also encouraging domestic instrument manufacturing, regional reagent production, and development of localized sequencing service providers.

The ngs-based rna-sequencing market research report is one of a series of new reports from The Business Research Company that provides ngs-based rna-sequencing market statistics, including ngs-based rna-sequencing industry global market size, regional shares, competitors with a ngs-based rna-sequencing market share, detailed ngs-based rna-sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the ngs-based rna-sequencing industry. This ngs-based rna-sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ngs-based rna-sequencing market size has grown exponentially in recent years. It will grow from $4.2 billion in 2025 to $5.27 billion in 2026 at a compound annual growth rate (CAGR) of 25.3%. The growth in the historic period can be attributed to expansion of genomic research initiatives, declining cost of sequencing technologies, increased use of rna-seq in academic research, availability of advanced sequencing platforms, growth of bioinformatics capabilities.

The ngs-based rna-sequencing market size is expected to see exponential growth in the next few years. It will grow to $12.73 billion in 2030 at a compound annual growth rate (CAGR) of 24.7%. The growth in the forecast period can be attributed to increasing adoption of rna sequencing in clinical diagnostics, rising investments in precision medicine, expansion of pharmaceutical research applications, growing demand for integrated data analysis solutions, increasing focus on multi-omics research. Major trends in the forecast period include increasing adoption of high-throughput rna sequencing platforms, rising demand for single-cell rna sequencing, growing use of cloud-based bioinformatics analysis, expansion of transcriptomics in precision medicine, enhanced focus on data accuracy and scalability.

The expanding pharmaceutical industry is anticipated to support the continued growth of the NGS-based RNA-sequencing market. The pharmaceutical industry encompasses the research, development, and manufacturing of drugs and medicines by both public and private organizations. Within this sector, NGS-based RNA-sequencing is widely used to perform comprehensive gene expression analysis, identify and validate potential drug targets, evaluate drug responses, and gain deeper insights into disease biology, thereby supporting more efficient and data-driven drug discovery and development. For example, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, North America accounted for 54.8% of global pharmaceutical sales in 2024, while Europe represented 22.7%. As a result, the expansion of the pharmaceutical industry is contributing significantly to the growth of the NGS-based RNA-sequencing market.

Leading companies active in the NGS-based RNA-sequencing market are increasingly concentrating on the development of innovative offerings such as advanced small RNA-sequencing kits to simplify workflows and enhance the precision and efficiency of RNA expression studies. These advanced small RNA-seq kits are next-generation library preparation solutions engineered to accurately capture and sequence small RNA molecules, enabling researchers to shorten processing times, reduce technical artifacts such as adapter dimers, and generate more consistent and reproducible expression data. For instance, in October 2025, Lexogen, an Austria-based biotechnology company, introduced the miRVEL Profiling Small RNA-Seq Library Prep Kit, which is designed to streamline and optimize small RNA research workflows. The kit enables the preparation of ready-to-sequence libraries in less than seven hours with limited hands-on time, incorporates advanced adapter-blocking technology to minimize adapter dimer formation, delivers reproducible performance across a wide range of input amounts, and includes integrated 8-nucleotide unique dual indices for accurate multiplexing and read assignment. The miRVEL Profiling Kit supports diverse applications such as RNA interference research, studies of host defense mechanisms, and plant and agricultural small RNA analysis, and is compatible with Lexogen's SPLIT RNA extraction kits and TraPR small RNA enrichment system, offering a comprehensive end-to-end solution for small RNA sequencing.

In November 2024, ARCHIMED SAS, a France-based private equity firm, acquired SeqCenter LLC for an undisclosed consideration. Through this acquisition, ARCHIMED sought to enhance its diagnostics and life-science tools portfolio by expanding SeqCenter's next-generation sequencing capabilities, accelerating international growth, and promoting innovation in high-throughput and cost-efficient DNA and RNA sequencing services. SeqCenter LLC is a United States-based genetic sequencing services provider specializing in fast, reliable, and affordable DNA and RNA sequencing solutions for use across research, biotechnology, diagnostics, agriculture, and environmental health applications.

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ngs-based rna-sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

NGS-Based RNA-Sequencing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ngs-based rna-sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ngs-based rna-sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ngs-based rna-sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product And Service: Sample Preparation Products; Sequencing Platforms and Consumables; Sequencing Services; Data Analysis, Storage, and Management
  • 2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing
  • 3) By Application: Expression Profiling Analysis; Small RNA Sequencing; De Novo Transcriptome Assembly
  • 4) By End User: Research & Academia; Pharmaceutical & Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Sample Preparation Products: RNA Extraction Kits; Library Preparation Kits; Reverse Transcription Kits; Quality Control Reagents
  • 2) By Sequencing Platforms And Consumables: Sequencing Instruments; Sequencing Consumables
  • 3) By Sequencing Services: Contract Sequencing Services; Custom Library Preparation Services; Consultation And Experimental Design Services
  • 4) By Data Analysis, Storage, And Management: Bioinformatics Software; Data Analysis Services; Cloud-Based Data Storage Solutions; Data Management Platforms
  • Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies Ltd.; Agilent Technologies Inc.; BGI Group; QIAGEN N.V.; Eurofins Scientific SE; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche Ltd.; Takara Bio Inc.; GENEWIZ Inc.; Novogene Corporation; Macrogen Inc.; Zymo Research Corp.; Lexogen GmbH; Partek Incorporated; GATC Biotech AG; Genohub LLC; BaseClear B.V.; Otogenetics Corporation; SeqLL LLC; GenXPro GmbH; Genotypic Technology Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. NGS-Based RNA-Sequencing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global NGS-Based RNA-Sequencing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. NGS-Based RNA-Sequencing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global NGS-Based RNA-Sequencing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of High-Throughput Rna Sequencing Platforms
    • 4.2.2 Rising Demand For Single-Cell Rna Sequencing
    • 4.2.3 Growing Use Of Cloud-Based Bioinformatics Analysis
    • 4.2.4 Expansion Of Transcriptomics In Precision Medicine
    • 4.2.5 Enhanced Focus On Data Accuracy And Scalability

5. NGS-Based RNA-Sequencing Market Analysis Of End Use Industries

  • 5.1 Research And Academia
  • 5.2 Hospitals And Clinics
  • 5.3 Pharmaceutical Companies
  • 5.4 Biotechnology Companies
  • 5.5 Genomics Service Providers

6. NGS-Based RNA-Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global NGS-Based RNA-Sequencing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global NGS-Based RNA-Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global NGS-Based RNA-Sequencing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global NGS-Based RNA-Sequencing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global NGS-Based RNA-Sequencing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global NGS-Based RNA-Sequencing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. NGS-Based RNA-Sequencing Market Segmentation

  • 9.1. Global NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
  • 9.2. Global NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
  • 9.3. Global NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly
  • 9.4. Global NGS-Based RNA-Sequencing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users
  • 9.5. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sample Preparation Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
  • 9.6. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Platforms And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sequencing Instruments, Sequencing Consumables
  • 9.7. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
  • 9.8. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Data Analysis, Storage, And Management, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

10. NGS-Based RNA-Sequencing Market Regional And Country Analysis

  • 10.1. Global NGS-Based RNA-Sequencing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global NGS-Based RNA-Sequencing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific NGS-Based RNA-Sequencing Market

  • 11.1. Asia-Pacific NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China NGS-Based RNA-Sequencing Market

  • 12.1. China NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India NGS-Based RNA-Sequencing Market

  • 13.1. India NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan NGS-Based RNA-Sequencing Market

  • 14.1. Japan NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia NGS-Based RNA-Sequencing Market

  • 15.1. Australia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia NGS-Based RNA-Sequencing Market

  • 16.1. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea NGS-Based RNA-Sequencing Market

  • 17.1. South Korea NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan NGS-Based RNA-Sequencing Market

  • 18.1. Taiwan NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia NGS-Based RNA-Sequencing Market

  • 19.1. South East Asia NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe NGS-Based RNA-Sequencing Market

  • 20.1. Western Europe NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK NGS-Based RNA-Sequencing Market

  • 21.1. UK NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany NGS-Based RNA-Sequencing Market

  • 22.1. Germany NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France NGS-Based RNA-Sequencing Market

  • 23.1. France NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy NGS-Based RNA-Sequencing Market

  • 24.1. Italy NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain NGS-Based RNA-Sequencing Market

  • 25.1. Spain NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe NGS-Based RNA-Sequencing Market

  • 26.1. Eastern Europe NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia NGS-Based RNA-Sequencing Market

  • 27.1. Russia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America NGS-Based RNA-Sequencing Market

  • 28.1. North America NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA NGS-Based RNA-Sequencing Market

  • 29.1. USA NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada NGS-Based RNA-Sequencing Market

  • 30.1. Canada NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America NGS-Based RNA-Sequencing Market

  • 31.1. South America NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil NGS-Based RNA-Sequencing Market

  • 32.1. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East NGS-Based RNA-Sequencing Market

  • 33.1. Middle East NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa NGS-Based RNA-Sequencing Market

  • 34.1. Africa NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. NGS-Based RNA-Sequencing Market Regulatory and Investment Landscape

36. NGS-Based RNA-Sequencing Market Competitive Landscape And Company Profiles

  • 36.1. NGS-Based RNA-Sequencing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. NGS-Based RNA-Sequencing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. NGS-Based RNA-Sequencing Market Company Profiles
    • 36.3.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. BGI Group Overview, Products and Services, Strategy and Financial Analysis

37. NGS-Based RNA-Sequencing Market Other Major And Innovative Companies

  • QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation

38. Global NGS-Based RNA-Sequencing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The NGS-Based RNA-Sequencing Market

40. NGS-Based RNA-Sequencing Market High Potential Countries, Segments and Strategies

  • 40.1 NGS-Based RNA-Sequencing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 NGS-Based RNA-Sequencing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 NGS-Based RNA-Sequencing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer